DR. GREGORY A ERTL, MD
Medical Practice at Catalina Dr, Yuma, AZ
License number
Arizona 19732
Category
Medical Practice
Type
Specialist
Address
Address
350 W Catalina Dr, Yuma, AZ 85364
Phone
(928) 344-0650
(928) 344-3928 (Fax)
(928) 344-3928 (Fax)
Organization information
See more information about GREGORY A ERTL at bizstanding.comGregory Ertl MD
1951 W 25 St, Yuma, AZ 85364
Industry:
Dermatologist
Phone:
(928) 344-0650 (Phone)
Description:
There is 1 doctor at this site. Surgery is not performed at this site.
Gregory Andrew Ertl
Professional information
Dr. Gregory A Ertl, Yuma AZ - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Palm Canyon Dermatology
350 W Catalina Dr, Yuma 85364
(928) 344-0650 (Phone)
350 W Catalina Dr, Yuma 85364
(928) 344-0650 (Phone)
Certifications:
Dermatology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Palm Canyon Dermatology
350 W Catalina Dr, Yuma 85364
Yuma Regional Medical Center
2400 Avenue South #A, Yuma 85364
350 W Catalina Dr, Yuma 85364
Yuma Regional Medical Center
2400 Avenue South #A, Yuma 85364
Education:
Medical School
Albany Medical College
Graduated: 1989
Good Samaritan Hosp
U Mc
Albany Medical College
Graduated: 1989
Good Samaritan Hosp
U Mc
Gregory A Ertl, Yuma AZ
Specialties:
Dermatologist
Address:
350 W Catalina Dr, Yuma, AZ 85364
12460 N Rancho Vistoso Blvd, Oro Valley, AZ 85755
12460 N Rancho Vistoso Blvd, Oro Valley, AZ 85755
Education:
Albany Medical College - Doctor of Medicine
Method Of Stimulation Of Melanin Production And Induction Of Skin Tanning
US Patent:
2005014, Jun 30, 2005
Filed:
Feb 25, 2003
Appl. No.:
10/504492
Inventors:
Robert Dorr - Tucson AZ, US
Norman Levine - Tucson AZ, US
Gregory Ertl - Yuma AZ, US
David Alberts - Tucson AZ, US
Norman Levine - Tucson AZ, US
Gregory Ertl - Yuma AZ, US
David Alberts - Tucson AZ, US
International Classification:
A61K038/08, A61K007/42
US Classification:
424059000, 514017000
Abstract:
A method of stimulating the production of melanin by the pigment-producing cells (keratinocytes and/or melanocytes) of the skin, in particular for the induction of skin tanning in humans, comprises administering alpha-MSH or an alpha-MSH analogue and exposing the skin to ultraviolet irradiation.